Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

3.133.91.171
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Thyroid Eye Disease

TED severely impacts quality of life even when disease is stable

Posted on

Even after acute thyroid eye disease (TED) symptoms have subsided, patients still feel the physical and psychosocial impacts of the disease, according to a study that found TED severely impacts patient quality of life (QOL).

Of the 100 patients who took part in an online survey on chronic TED symptoms and patient QOL, 34% reported a high prevalence of anxiety, and 28% reported experiencing depression. On average, patients reported 20 doctor visits per year.

-Advertisement-

Participants had undergone treatments including systemic corticosteroids during active TED (25%), orbital radiation (5%), and surgery (25%).

Overall Graves’ Ophthalmopathy QOL score, which takes into account overall; appearance; and vision-related QOL, was 60.5 ± 21.8. Hypothyroidism, anxiety, and more chronic TED symptoms were reported more frequently in patients with low QOL.

Patients with low QOL had more pain (39%), blurry vision (30%), and diplopia (27%) compared to patients with high QOL (13%, 17%, and 3%, respectively).

Participants with low QOL had more surgery related to TED, disability/unemployment, and doctor appointments.

Reference
Cockerham KP, Padnick-Silver L, Stuertz N, et al. Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States. Ophthalmol Ther. 2021;doi: 10.1007/s40123-021-00385-8. Epub ahead of print. PMID: 34478126.

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-